Articles written specifically for the GLP or the articles that are reposted from other sources (sometimes in modified form) with permission list the source as Genetic Literacy Project. Excerpted articles list the original media outlet as the source. Excerpts are posted under guidelines for Fair Use and Creative Commons for educational nonprofits (501c3). The GLP’s Fair Use policy for posting excerpts and using images is explained here.
vs

Regeneron’s COVID-19 antibody ‘cocktail’ therapy enters clinical trials—could be ready for emergency use in the fall

Wall Street Journal | 
Regeneron Pharmaceuticals Inc. said [June 11 that] it is beginning to test in humans a potential coronavirus drug, the latest ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists